Dianthus Therapeutics, Inc. Common Stock

DNTH XNAS • PHARMACEUTICAL PREPARATIONS

Historical Short Interest Share

American Express® Business Gold Card

Earn Up to 200K Membership Rewards® Points

4X on your top 2 spending categories. Transfer to 20+ airline & hotel partners. Terms apply.

Learn More

Market Cap

4.5B

Short interest (May 15)

11.8%

Net Short (Jun 03 ): 0.0%

Borrow Fee

0.27%

↓ 7.2%

Available Shares

900K

↓ 25.6%

Price Chart

Company Overview

Dianthus Therapeutics Inc. is a clinical-stage biotechnology company dedicated to developing potentially best-in-class therapies for patients with severe autoimmune diseases. The company operates as a single segment and has one reportable segment, focusing on creating next-generation treatments to revolutionize the management of severe autoimmune conditions. The team comprises experienced biotech and pharma executives. The pipeline includes the potential of Claseprubart, a next-generation complement therapeutic.

Company Info

Exchange: NASDAQ

Industry: PHARMACEUTICAL PREPARATIONS

CIK: 0001690585

Asset Type: CS

Market Data

Market Cap: $4,459,124,625

Employees: 92

Status: Active

Short Interest

Current Borrow Fee 0.27%

Range: 0.27% - 0.27%

Available Shares 900K

Range: 650K - 850K

Recent Changes

Fee Change: ↓ 13.1%

Available Change: ↑ 18.5%

Quick Actions

View Dilution Chart

Add to Watchlist Set Price Alert View Options Chain

Investment Risk

This is not financial advice. All investments carry risk. Do your own research before making investment decisions.

Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam • Unsubscribe anytime